Advertisement
Advertisement

GPCR

GPCR logo

Structure Therapeutics Inc. - ADR

39.10
USD
Sponsored
-0.05
-0.13%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

39.55

+0.45
+1.16%

Structure Therapeutics Inc. - ADR Profile

About

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.

Info & Links

CEO

Raymond Stevens

Headquarters

601 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.structuretx.com

Auditor

Ernst & Young LLP

Share holders

21

Employees

220

Structure Therapeutics Inc. - ADR Statistics

Valuation Measures

Market Capitalization2

2.81B

Enterprise Value

2.50B

Enterprise Value/EBITDA(ttm)

-12.13

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.21

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-25.90%

Return on Invested Capital(ttm)

-20.02%

Return on Assets(ttm)

-24.54%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-205.70M

Net Income Available to Common(ttm)

-170.34M

Diluted EPS(ttm)

-0.79

Share Statistics

Beta (5Y Monthly)

-1.17

52-Week Change

45.79%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

71.07M

Dividend Yield

0.00%

Float4

66.88M

% Held by Insiders

5.60%

% Held by Institutions

91.78%

Balance Sheet

Total Cash(mrq)

1.46B

Total Cash Per Share(mrq)

20.52

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

24.81%

Quick Ratio(mrq)

24.81%

Book Value Per Share(mrq)

21.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.75

Free Cash Flow(ytd)

-225.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement